Quantification of asenapine and three metabolites in human plasma using liquid chromatography-tandem mass spectrometry with automated solid-phase extraction: application to a phase I clinical trial with asenapine in healthy male subjects.

@article{Boer2012QuantificationOA,
  title={Quantification of asenapine and three metabolites in human plasma using liquid chromatography-tandem mass spectrometry with automated solid-phase extraction: application to a phase I clinical trial with asenapine in healthy male subjects.},
  author={T. de Boer and Erik A. Meulman and H. Meijering and J. Wieling and P. Dogterom and Holger Lass},
  journal={Biomedical chromatography : BMC},
  year={2012},
  volume={26 2},
  pages={
          156-65
        }
}
  • T. de Boer, Erik A. Meulman, +3 authors Holger Lass
  • Published 2012
  • Chemistry, Medicine
  • Biomedical chromatography : BMC
  • The development and validation of methods for determining concentrations of the antipsychotic drug asenapine (ASE) and three of its metabolites [N-desmethylasenapine (DMA), asenapine-N(+) -glucuronide (ASG) and 11-O-sulfate-asenapine (OSA)] in human plasma using LC-MS/MS with automated solid-phase extraction is described. The three assessment methods in human plasma were found to be acceptable for quantification in the ranges 0.0250-20.0 ng/mL (ASE), 0.0500-20.0 ng/mL (DMA and OSA) and 0.250-50… CONTINUE READING
    35 Citations

    Figures, Tables, and Topics from this paper.

    Determination of asenapine in presence of its inactive metabolites in human plasma by LC-MS/MS
    • 6
    • Highly Influenced

    References

    SHOWING 1-10 OF 13 REFERENCES
    High throughput therapeutic drug monitoring of clozapine and metabolites in serum by on-line coupling of solid phase extraction with liquid chromatography-mass spectrometry.
    • 50
    Metabolism and Excretion of Asenapine in Healthy Male Subjects
    • 35
    • PDF
    Asenapine: a novel psychopharmacologic agent with a unique human receptor signature
    • 253
    • Highly Influential
    Efficacy and Safety of Asenapine in a Placebo- and Haloperidol-Controlled Trial in Patients With Acute Exacerbation of Schizophrenia
    • 98
    Asenapine versus olanzapine in acute mania: a double-blind extension study.
    • 107
    Efficacy and tolerability of asenapine in acute schizophrenia: a placebo- and risperidone-controlled trial.
    • 144
    Bioanalytical Method Validation—A Revisit with a Decade of Progress
    • 1,526
    Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.
    • 575
    • Highly Influential